Howard H Feldman
University of California, San Diego
H-index: 99
North America-United States
Top articles of Howard H Feldman
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
A multicenter, randomized, double-blind, placebo-controlled ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects of … | O Mcelvaney N McEvoy F Boland OF Mcelvaney G Hogan | 2022/5 | |
Baseline Characteristics from Evoke and Evoke+: Two Phase 3 Randomized Placebo-controlled Trials of Oral Semaglutide in Patients with Early Alzheimer’s Disease (P11-9.013) | Philip Scheltens Alireza Atri Howard Feldman Oskar Hansson Filip Knop | 2024/4/14 | |
Developing the Healthy Actions and Lifestyles to Avoid Dementia or Hispanos y el ALTo a la Demencia program | Alzheimer's & Dementia: Translational Research & Clinical Interventions | Sara Moukarzel Zvinka Z Zlatar Sheri J Hartman Derek Lomas Howard H Feldman | 2024/1 |
Clinical value of Alzheimer's disease biomarker testing | Alzheimer's & Dementia: Translational Research & Clinical Interventions | Khushbu J Patel David Yang John R Best Colleen Chambers Philip E Lee | 2024/4 |
Potentially Modifiable Dementia Risk Factors in Canada: An Analysis of Canadian Longitudinal Study on Aging with a Multi-Country Comparison | medRxiv | Surim Son Mark Speechley Guangyong Zou Miia Kivipelto Francesca Mangialasche | 2024 |
Personal value of Alzheimer's disease biomarker testing and result disclosure from the patient and care partner perspective | Alzheimer's & Dementia: Translational Research & Clinical Interventions | Khushbu J Patel David Yang Howard H Feldman Ging‐Yuek R Hsiung Haakon B Nygaard | 2024/4 |
Efficacy assessment of an active tau immunotherapy in Alzheimer’s disease patients with amyloid and tau pathology: a post hoc analysis of the “ADAMANT” randomised, placebo … | EBioMedicine | Nicholas C Cullen Petr Novak Duygu Tosun Branislav Kovacech Jozef Hanes | 2024/1/1 |
Evoke et evoke+: design de deux études de phase 3 randomisées en double aveugle, contrôlées par placebo, évaluant les effets neuroprotecteurs du semaglutide dans la maladie d … | Revue Neurologique | Claude Guériot Alireza Atri Howard H Feldman Charlotte Thim Hansen Julie Broe Honore | 2024/4/1 |
Asian Cohort for Alzheimer's Disease (ACAD) pilot study on genetic and non‐genetic risk factors for Alzheimer's disease among Asian Americans and Canadians | Alzheimer's & Dementia | Pei‐Chuan Ho Wai Haung Yu Boon Lead Tee Wan‐Ping Lee Clara Li | 2024/1/12 |
Impact of a national dementia research program-CCNA-in Canada | Journal of the Neurological Sciences | Howard Chertkow Natalie Phillips Kenneth Rockwood Pedro Rosa-Neto Eric Smith | 2023/12/1 |
Associations between neuropsychiatric symptoms of affective and vegetative domains and brain morphology in aging people with mild cognitive impairment and Alzheimer's disease | International journal of geriatric psychiatry | Adriana Cannizzaro Lucas Ronat Lyna Mariam El Haffaf Alexandru Hanganu ADNI | 2023/6 |
Anatomically interpretable deep learning of brain age captures domain-specific cognitive impairment | Proceedings of the National Academy of Sciences | Chenzhong Yin Phoebe Imms Mingxi Cheng Anar Amgalan Nahian F Chowdhury | 2023/3/10 |
Prevalence and clinical implications of a β-Amyloid–Negative, tau-positive cerebrospinal fluid biomarker profile in Alzheimer disease | JAMA neurology | Pontus Erickson Joel Simrén Wagner S Brum Gilda E Ennis Gwendlyn Kollmorgen | 2023/9/1 |
CAN‐THUMBS UP: Recruitment in the Virtual Era | Alzheimer's & Dementia | Haakon B Nygaard Penelope Slack Howard H Feldman Howard Chertkow Sylvie Belleville | 2023/12 |
CSF tau markers are associated with fine memory discrimination in older adults with amnestic MCI in the EXERT trial | Alzheimer's & Dementia | Laura E Fenton Vahan Aslanyan Diane M Jacobs David P Salmon James B Brewer | 2023/12 |
Virtual cognitive testing in the BHSP-neuropsychology, MyCogHealth and Cogniciti | Journal of the Neurological Sciences | Paul Brewster Scott Hofer Nathan Lewis Diane Jacobs Howard Feldman | 2023/12/1 |
Canadian Consortium on Neurodegeneration in Aging (CCNA) Partners Forum and Science Days 2022: Abstracts from the Poster Sessions, October 11–14, 2022 | Canadian Geriatrics Journal: CGJ | Y Costa A Lim K Thorpe D Colelli S Mitchell | 2023/3/1 |
Evaluation of bumetanide as a potential therapeutic agent for Alzheimer’s disease | Ben Boyarko Sonia Podvin Barry Greenberg Jeremiah D Momper Yadong Huang | 2023/8/4 | |
Canadian Patient and Care Partner Perspectives on Diagnostic Biomarker Testing for Alzheimer's Disease | Canadian Geriatrics Journal | Khushbu J Patel Howard H Feldman David Yang Ging-Yuek R Hsiung Haakon B Nygaard | 2023/6/1 |
Asian Cohort for Alzheimer’s Disease Pilot Study on Genetic and Non‐Genetic Risk Factors for Alzheimer’s Disease among Asian Americans and Canadians | Alzheimer's & Dementia | Li‐San Wang Pei‐Chuan Ho Boon Lead Tee Clara Li Yian Gu | 2023/12 |
